Ngo et al. The Protein Folding Problem and Tertiary Structure Prediction, Merz et al. Birkhauser, Boston, MA pp 433 and 492-495, 1994.* |
Aebersold et al., “Lysis of Autologous Melanoma Cells by Tumor-Infiltrating Lymphocytes: Association With Clinical Response,” Journal of the National Cancer Institute, 83(13):932-937, Jul. 1991. |
Anderson et al., “Intracellular Transport of Class I MHC Molecules in Antigen Processing Mutant Cell Lines,” The Journal of Immunology, 151:3407-3419, Oct. 1993. |
Bednarek et al., “The Minimum Peptide Epitope from the Influenza Virus Matrix Protein,” The Journal of Immunology, 147:4047-4053, Dec. 1991. |
Bednarek et al., “Soluble HLA-A2.1 restricted peptides that are recognized by influenza virus specific cytotoxic T lymphocytes,” Journal of Immunological Methods, 139:41-47, 1991. |
Bowness et al., “Conservation of T cell receptor usage by HLA B27-restricted influenza-specific cytotoxic T lymphocytes suggests a general pattern for antigen-specific major histocompatibility complex class I-restricted responses,” Eur. J. Immunol., 23:1417-1421, 1993. |
Brichard et al., “The Tyrosinase Gene Codes for an Antigen Recognized by Autologous Cytolytic T Lymphocytes on HLA-A2 Melanomas,” J. Exp. Med., 178:489-496, Aug. 1993. |
Carbone et al., “Induction of Cytotoxic T Lymphocytes by Primary In Vitro Stimulation with Peptides,” J. Exp. Med., 167:1767-1779, Jun. 1988. |
DiBrino et al., “Endogenous Peptides with Distinct Amino Acid Anchor Residue Motifs Bind to HLA-A1 and HLA-B8,” Journal of Immunology, 152:620-631, 1994. |
Fisk et al., “Oligopeptide Induction of a Cytotoxic T Lymphocyte Response to HER-2/Neu Proto-oncogene in Vitro,” Cellular Immunology, 157:415-427, 1994. |
Fisk et al., “Sequence motifs on human HER-2 proto-oncogene important for peptide binding to HLA-A2,” International Journal of Oncology, 5:51-63, 1994. |
Houbiers et al., “In vitro induction of human cytotoxic T lymphocyte responses against peptides of mutant and wild-type p53,” Eur. J. Immunol., 23:2072-2077, 1993. |
Hu et al., “An Evaluation of the Potential to Use Tumor-associated Antigens as Targets for Antitumor T Cell Therapy Using Transgenic Mice Expressing a Retroviral Tumor Antigen in Normal Lymphoid Tissues,” J. Exp. Med., 177:1681-1690, Jun. 1993. |
Ioannides et al., “Cytotoxic T Cell Clones Isolated from Ovarian Tumor-Infiltrating Lymphocytes Recognize Multiple Antigenic Epitopes on Autologous Tumor Cells,” The Journal of Immunology, 146(5):1700-1707, Mar. 1991. |
Ioannides et al., “Cytotoxic T Cells Isolated from Ovarian Malignant Ascites Recognize a Peptide Derived from the HER-2/neu Proto-oncogene,” Cellular Immunology, 151:225-234, 1993. |
Ioannides et al., “T-Cell Recognition of Oncogene Products: A New Strategy for Immunotherapy,” Molecular Carcinogenesis, 6:77-82, 1992. |
Ioannides et al., “Tumor Cytolysis by Lymphocytes Infiltrating Ovarian Malignant Ascites,” Cancer Research, 51:4257-4265, Aug. 1991. |
Ioannides et al., “Cytotoxic T-Cell Clones Isolated from Ovarian Tumour Infiltrating Lymphocytes Recognize Common Determinants on Non-Ovarian Tumour Clones,” Scand. J. Immunol., 37:413-424, 1993. |
Jerome et al., “Tumor-Specific Cytotoxic T Cell Clones from Patients with Breast and Pancreatic Adenocarcinoma Recognize EBV-Immortalized B Cells Transfected with Polymorphic Epithelial Mucin Complementary DNA,” The Journal of Immunology, 151(3):1654-1662, Aug. 1993. |
Madden et al., “The Antigenic Identity of Peptide-MHC Complexes: A Comparison of the Conformations of Five Viral Peptides Presented by HLA-A2,” Cell, 75:693-708, Nov. 1993. |
Marincola et al., “HLA Association with Response and Toxicity in Melanoma Patients Treated with Interleukin 2-based Immunotherapy,” Cancer Research, 52:6561-6566, Dec. 1992. |
Parker et al., “Sequence Motifs Important for Peptide Binding to the Human MHC Class I Molecule, HLA-A2,” The Journal of Immunology, 149(11):3580-3587, Dec. 1992. |
Ratner and Clark, “Role of TNG-α in CD8° Cytotoxic T Lymphocyte-Mediated Lysis,” The Journal of Immunology, 150(10):4303-4314, May 1993. |
Schmidt et al., “Oligopeptide Induction of a Seconary Cytotoxic T-cell Response to Esptein-Barr Virus In Vitro,” Scand. J. Immunol., 33:411-420, 1991. |
Slamon et al., “Studies of the HER-2/neu Proto-oncogene in Human Breast and Ovarian Cancer,” Science, 244:707-712, May 1989. |
Suhrbier et al., “Peptide Epitope Induced Apoptosis of Human Cytotoxic T Lymphocytes,” The Journal of Immunology, 159(6): 2169-2178, Mar. 1993. |
Wölfel et al., “Lysis of Human Pancreatic Adenocarcinoma Cells by Autologous HLA-Class I-Restricted Cytolytic T-Lymphocyte (CTL) Clones,” Int. J. Cancer, 54:636-644, 1993. |
Zweerink et al., “Presentation of Endogenous Peptides to MHC Class I-Restricted Cytotoxic T Lymphocytes in Transport Deletion Mutant T2 Cells,” The Journal of Immunology, 150(5):1763-1771, Mar. 1993. |